CARe - Centre for Antibiotic Resistance Research at University of Gothenburg – has a vision to limit mortality, morbidity and socioeconomic costs related to antibiotic resistance on a global scale through research. CARe offers diverse expertise representing six faculties and a broad network of stakeholders within the health care sector and beyond to generate state-of-the-art science with the intention to support rapid revision of policies and their implementation.
Videos
[26 May 2020] We present an assay that is capable of identifying bacteria directly from uncultured clinical urine samples, as well as in mixtures, with the potential to be discriminative even at the subspecies level.
[18 May 2020] Davis, Mark, Lyall, Benjamin, Whittaker, Andrea, Lindgren, Mia, Djerf-Pierre, Monika, Flowers, Paul. (2020). A year in the public life of superbugs: News media on antimicrobial resistance and implications for health communications, Social Science & Medicine
[2 May 2020] Hospital screening of patients for antibiotic resistant bacteria is a backbone of good antibiotic stewardship. In a new original research article, published in the established healthcare ethical journal Monah Bioethics Review, an interdisciplinary group of CARe researchers argue for reform of existing hospital screening programs to detect colonization of multi-drug resistant gram-negative (MDRGN) bacteria in patients.
[27 Mar 2020] Aminoglycoside antibiotics are critically important for treating several types of infections with multi-resistant bacteria. A completely new resistance gene, which is likely to counteract the newest aminoglycoside-drug plazomycin, was recently discovered by scientists at the University of Gothenburg.
[27 Feb 2020] CARe researcher Johan Bengtsson-Palme has been awarded the first best article award from FEMS Microbiology Reviews for the 2018 review "Environmental factors influencing the development and spread of antibiotic resistance", co-authored with fellow CARe researchers Joakim Larsson and Erik Kristiansson.
[18 Feb 2020] Erik Malmqvist, forskare på CARe, diskuterar antibiotika och vad det spelar för roll när många andra länder har en helt annan inställning än Sverige när det gäller utskrivning och användning. Och vilket ansvar har du och jag?
[14 Feb 2020] In a 2013 paper published in Lancet Infectious Diseases, the state of antimicrobial resistance worldwide was described. This follow-up paper, led by Ramanan Laxminarayan and coauthored by several leading scientists on antimicrobial resistance across the world, describes what has changed since then.
"This serious threat is no longer a prediction for the future, it is happening right now in every region of the world and has the potential to affect anyone, of any age, in any country"
"Without urgent, coordinated action by many stakeholders, the world is headed for a post-antibiotic era, in which common infections and minor injuries which have been treatable for decades can once again kill"
(World Health Organization 2014 regarding the global challenges with antibiotic resistance)
“It is not difficult to make microbes resistant to penicillin in the laboratory by exposing them to concentrations not sufficient to kill them… There is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant.”
(Alexander Flemming, Nobel Lecture, December 11, 1945)
"Ethics and Value Challenges in Antibiotic Resistance Management, Policy and Research Symposium"
See all talks from the first ever major international conference on this topic.
This completely new Nordic educational program at the University of Gothenburg is under development. Note that the information on this website is continuously updated.
2021 - Gothenburg POSTPONED to 2022
